Invention Grant
US09592260B2 Cancer therapy with a parvovirus combined with an HDAC inhibitor
有权
用细胞病毒与HDAC抑制剂结合的癌症治疗
- Patent Title: Cancer therapy with a parvovirus combined with an HDAC inhibitor
- Patent Title (中): 用细胞病毒与HDAC抑制剂结合的癌症治疗
-
Application No.: US14507160Application Date: 2014-10-06
-
Publication No.: US09592260B2Publication Date: 2017-03-14
- Inventor: Antonio Marchini , Jean Rommelaere , Nazim El-Andaloussi , Georgi Hristov , Junwei Li
- Applicant: Deutsches Krebsforschungszentrum
- Applicant Address: DE Heidelberg
- Assignee: Deutsches Krebsforschungszentrum
- Current Assignee: Deutsches Krebsforschungszentrum
- Current Assignee Address: DE Heidelberg
- Agency: Crowell & Moring LLP
- Priority: EP10002829 20100317
- Main IPC: A61K35/76
- IPC: A61K35/76 ; A61K35/768 ; A61K31/165 ; A61K31/19 ; A61K45/06
Abstract:
Described is a pharmaceutical composition comprising (a) a parvovirus and (b) a histone deacetylase inhibitor (HDACI) and the use of said composition for treatment of cancer, e.g., brain tumor, cervical carcinoma, or pancreatic carcinoma.
Public/Granted literature
- US20150030567A1 Cancer Therapy with a Parvovirus Combined with an HDAC Inhibitor Public/Granted day:2015-01-29
Information query
